Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1179910

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1179910

Global Non-Invasive Blood Pressure Monitors Market - 2023-2030

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Market Overview

The global non-invasive blood pressure monitors market size was valued US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 7.0% during the forecast period (2023-2030).

Blood pressure monitors are used in hospitals to measure the blood pressure of patients who are critically ill or will be operated on for any surgical procedure. Blood pressure monitors are used in the operating room, intensive care units, surgical recovery rooms, emergency departments, and other critical care areas to measure blood pressure regularly or continuously. Blood pressure is checked during a patient's critical condition because it plays an important role in diagnosis.

Market Dynamics

The global rise of hypertension and cardiovascular diseases and governmental control, the rising geriatric population, and technological advancement in non-invasive blood pressure monitors are the factors to drive the market in the forecast period.

Ongoing research for non-invasive blood pressure monitors is expected to drive market growth.

BPro (Healthstats, Singapore) is a wristwatch radial artery tonometer for ambulatory blood pressure measurement. It is calibrated with a brachial cuff device at first. The watch provides accurate results for at least 24 hours after calibration. The device comprises a watch head with a simple graphic user interface and a plunger to be pressed against the radial artery. The plunger is taped to the wrist by the healthcare professional performing the calibration to prevent it from moving while in use. The device has been validated in accordance with the AAMI and ESH standards, with SBP and DBP readings of (0.9 7.6) mmHg and (1.1 6.1) mmHg, respectively.

Furthermore, in 2020, a research group at the University of Turku proposed a tabletop form factor blood pressure instrument, the finger artery non-invasive tonooscillometric monitor (FANTOM). A tonometric cuffless mechatronic system is used to apply pressure to the fingertip and measure blood pressure using an oscillometric method. The device can measure arterial waveforms and central blood pressure (CBP). An arbitrary validation protocol comparing the device to an automated arm cuff monitor produced SBP and DBP results of (0.9 7.3) mmHg and (3.3 6.6) mmHg, respectively. Therefore, the ongoing research for cuffless non-invasive blood pressure monitors is expected to drive in the forecast period.

Drawbacks of non-invasive blood pressure measurements are expected to hamper market growth.

Non-invasive blood pressure measurement is less reliable at pressure extremes, and continuous monitoring is not possible; it can be painful if set to repeat too frequently and requires manual operation for maximum accuracy (i.e., automatic modes are unreliable in unstable patients). Thus, from the above factors, the market is expected to be hampered in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has impacted the non-invasive blood pressure monitors market moderately. Experts realized that COVID-19 was especially dangerous for people with heart disease and related conditions, especially high blood pressure when cases of the virus started to rise globally. One hundred three million adults in the United States, or nearly half of all adults, have high blood pressure, also referred to as hypertension. Even more concerning is the fact that only 1 in 4 adults have their blood pressure under control. Uncontrolled blood pressure can result in severe complications like heart attack and stroke. As COVID-19 outbreaks persisted, a new issue surfaced. High blood pressure sufferers may be susceptible to more fatal and severe coronavirus side effects. As a result, there is now more of a demand for non-invasive blood pressure monitors.

In addition, COVID-19 has another potentially harmful effect. It has caused many patients to avoid their local hospitals and emergency rooms because they might contract the coronavirus. Hospitals across the nation are reporting a decrease in visits for urgent medical needs. Still, some experts think this isn't because patients are experiencing fewer of them rather than because they are putting off or postponing seeking treatment. Thus, from the above factors, the market got affected and is expected to improve in the forecast period.

Segment Analysis

Digital segment is expected to hold the largest market share in non-invasive blood pressure monitors

The digital segment accounted for the largest market share in 2021. The convenience that a digital blood pressure monitor provides in its mode of operation. They are ideal for use at home, particularly if the patient takes blood pressure readings. They employ electronic pressure sensors to assist in the measurement of blood pressure. As a result, readings are displayed digitally on a screen. A digital blood pressure monitor will help save time. It will save the patient from paying unnecessary fees to doctors who help you monitor their blood pressure. While most are battery-powered, some models are designed for field use and have dual power sources, including solar and battery cells.

Furthermore, digital blood pressure monitors are an excellent choice for people who have hearing or vision impairments. Some even provide paper printouts to assist you in keeping records. This helps your doctor evaluate your health at your next appointment. Therefore, it has increased the demand for digital non-invasive blood pressure monitors. Thus, from the above factors, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global non-invasive blood pressure monitors market

North America region accounted for the largest market share in 2021. The rising geriatric population, rising incidence of hypertension, increasing prevalence of cardiovascular disease, technological advancement in non-invasive blood pressure monitors, and product launches by the market players are the factors driving market growth in the forecast period. For instance, according to the Centers for Disease Control and Prevention, Hypertension increases the risk of heart disease and stroke, which are the leading causes of death in the United States. Hypertension was a primary or contributing cause of more than 670,000 deaths in the United States in 2020. Only about one in every four adults (24%) has hypertension under control. Uncontrolled hypertension affects roughly half of all adults (45%), with a blood pressure of 140/90 mmHg or higher. This includes 37 million adults in the United States.

Furthermore, On August 31, 2022, Sensifree LTD received a CE certificate for SentiCor-100 in compliance with the new EU MDR. SentiCor-100 is the world's first PPG-based Continuous Non-Invasive Blood Pressure (cNIBP) monitoring device approved for hospital use. Thus, from the above factors, the North American region accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the non-invasive blood pressure monitors market are GE Healthcare, SOMNOmedics, Eccosur SA, Koninklijke Philips N.V., Huntleigh Technology Ltd., Mortara Instrument, Schiller Americans Inc., American Diagnostic Corporation and Welch Allyn.

GE Healthcare:

Overview:

GE Healthcare is a subsidiary of the American multinational conglomerate General Electric Company. The company manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures as of 2017. Dyes for magnetic-resonance imaging methods are available from the firm. GE Healthcare also manufactures medical diagnostic equipment, including CT image machines. Moreover, it develops Health technology for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing. The company is operated in more than 100 countries.

Product Portfolio:

CRITIKON SOFT-CUF Blood Pressure Cuffs: CRITIKON SOFT-CUF is made of soft, absorbent material with rounded corners to maximize patient comfort during long hospital stays. These cuffs are ideal for patients with longer-term stays or protocols in which the cuff travels with the patient throughout their stay. It can be cleaned and reused on multiple patients. Still, it is reasonably priced so that it can be discarded after single-patient use, allowing for preventing infections more affordably.

The global non-invasive blood pressure Monitors market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Product Code: DMMD56

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Ongoing research for non-invasive blood pressure monitors is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. Drawbacks of non-invasive blood pressure measurements are expected to hamper market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Supply Chain
  • 5.3. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Automated BP Monitors*
      • 7.2.1.1. Introduction
      • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Ambulatory BP Monitors
  • 7.4. Sphygmomanometers
  • 7.5. BP Transducers

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Digital*
      • 8.2.1.1. Introduction
      • 8.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Aneroid
  • 8.4. Wearable

9. By Accessory

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 9.1.2. Market Attractiveness Index, By Accessory
  • 9.2. Blood Pressure Cuffs*
      • 9.2.1.1. Introduction
      • 9.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Manometers
  • 9.4. Valves and Tubing
  • 9.5. Bulbs

10. By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By End user
  • 10.2. Hospitals*
      • 10.2.1.1. Introduction
      • 10.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Clinics
  • 10.4. Ambulatory Surgical Center
  • 10.5. Home Care Setting
  • 10.6. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. GE Healthcare*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. SOMNOmedics
  • 13.3. Eccosur SA
  • 13.4. Koninklijke Philips N.V.
  • 13.5. Huntleigh Technology Ltd.
  • 13.6. Mortara Instrument
  • 13.7. Schiller Americans Inc.
  • 13.8. American Diagnostic Corporation
  • 13.9. Welch Allyn

LIST NOT EXHAUSTIVE

14. Global Non-Invasive Blood Pressure Monitors Market- DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!